
X4 and taiba to distribute WHIM syndrome therapy in Middle East
US-based X4 Pharmaceuticals has entered an exclusive agreement with United Arab Emirates (UAE)-based pharmaceutical products wholesaler taiba rare to distribute and commercialise oral Xolremdi (mavorixafor) in select Middle Eastern countries for the …